Home›Testicular cancer
Testicular cancer
It is the commonest tumour in young men and, at the same time, the most curable solid cancer there is: cured in more than 95% of cases, and cured in most patients even once it has spread. What is at stake is not so much survival as how much treatment will be needed to reach it. Here you will find what to look for, which mistakes to avoid from day one, and why in early stage the right course is usually to watch rather than treat further.
The essentials
- It is the most curable solid cancer there is. It is cured in more than 95% of cases, and even once it has spread most patients are cured.
- It is the commonest tumour in men aged 15 to 35, precisely the age at which people least seek help and most put things off.
- A testicle is never biopsied through the scrotum. Doing so alters the lymphatic drainage and can change the treatment you will need afterwards. This is the most important warning in this guide.
- Bank sperm before starting any treatment. It is a decision that cannot be undone and one that is forgotten with painful frequency.
- In most early-stage cases, the right course after surgery is surveillance, not further treatment.
How it presents
Almost always as a painless lump or firmness in the testicle, found by the patient himself. It is sometimes accompanied by a feeling of heaviness, an increase in size, or a dull ache mistaken for a knock.
- Painlessness is not reassuring. On the contrary: the absence of pain is the most characteristic feature.
- It can be mistaken for epididymitis, and is in fact often treated first with antibiotics. If it does not settle within one or two weeks, it must be reassessed with ultrasound.
- Less often it presents with breast tissue enlargement, back pain from enlarged nodes, or respiratory symptoms.
Why delay is the real problem
This is a tumour that grows fast. Within a few months it can go from being confined to the testicle to having metastases. And it is also the cancer where consultation is most postponed, because it affects young men who do not visit doctors and who are additionally uncomfortable about the reason.
Put plainly: the difference between being cured by an operation and being cured by an operation plus several cycles of chemotherapy is usually measured in weeks of waiting. Both scenarios end well in the great majority of cases. But one of the two costs you a great deal more.
How it is diagnosed
- Testicular ultrasound. It is the first investigation and is very accurate at distinguishing a mass within the testicle from an epididymal problem or a hydrocele.
- Blood tumour markers: alpha-fetoprotein, chorionic gonadotropin and lactate dehydrogenase. They are measured before and after surgery, and their behaviour provides information no other test gives.
- CT of the chest, abdomen and pelvis to determine the extent.
The warning with the greatest consequences
The definitive diagnosis is not made by biopsy. It is made by removing the testicle through an incision in the groin —radical inguinal orchidectomy— with control of the spermatic cord before the tumour is handled.
The reason is anatomical: the testicle drains its lymph to the retroperitoneal nodes, not to the groin. Puncturing or opening the scrotum creates a route of spread that did not exist and forces the subsequent treatment to be altered. If someone proposes a biopsy through the scrotum, seek a second opinion before agreeing to it.
Before any treatment: fertility
This section comes before treatment deliberately, because in clinical practice it comes afterwards, and that is precisely the problem.
- Bank sperm before surgery, and certainly before any chemotherapy or radiotherapy. It is quick, accessible and delays nothing.
- Many patients already have reduced semen quality because of the tumour itself, before any treatment at all.
- One healthy testicle is usually enough to preserve fertility and normal hormone levels, but not always, and that cannot be known in advance.
- If you wish, a testicular prosthesis can be placed during the same operation. It is a conversation worth having beforehand, not afterwards.
Seminoma and non-seminoma: why the difference matters
All germ cell tumours of the testicle fall into two broad groups, and that division organises the whole of treatment.
| Seminoma | Non-seminoma | |
|---|---|---|
| Typical age | Somewhat older, between 30 and 40 | Younger, between 20 and 30 |
| Markers | Gonadotropin may rise. Alpha-fetoprotein never rises: if it does, it is not a pure seminoma | Alpha-fetoprotein, gonadotropin or both frequently raised |
| Speed | Grows more slowly | More aggressive and faster growing |
| Early stage | Surveillance as the preferred option; alternatively, one dose of chemotherapy | Surveillance as the preferred option; alternatively, one cycle of chemotherapy or node dissection |
| Treatment sensitivity | Highly sensitive to both chemotherapy and radiotherapy | Chemosensitive; radiotherapy plays no part in treatment |
| Residual mass after chemotherapy | Usually monitored; PET helps decide | Surgically removed when it exceeds a centimetre |
| Cure in early stage | Virtually 100% | Virtually 100% |
In fairness to the evidence
Look at the last row and the fourth at the same time. In early stage cure is virtually complete in both groups, and surveillance achieves the same result as giving additional treatment. The difference is that surveillance spares chemotherapy to the great majority, who were already cured by the surgery.
That is why current guidelines prefer surveillance in stage I, even though a proportion of patients relapse and need treatment then. It is a counter-intuitive decision —doing less— and it has to be explained well, because nobody finds it comfortable to leave a consultation with a diagnosed cancer and no treatment prescribed.
There is one condition for it to work and it is not negotiable: keeping to the surveillance schedule. A patient who does not attend his checks is worse off on surveillance than on treatment.
Once it has spread
Here is the fact that sets this tumour apart from all others: even with metastases, most patients are cured. Not controlled: cured. It is the result of a cisplatin-based chemotherapy regimen that transformed the disease in the 1970s and remains the basis of treatment.
- The outlook is classified into three groups —good, intermediate and poor— according to the markers and the location of the metastases. Even in the unfavourable group cure is possible.
- After chemotherapy a residual mass in the retroperitoneum may remain. In non-seminomas it is removed by retroperitoneal lymph node dissection, because it may contain viable tumour or teratoma, which does not respond to further chemotherapy.
- That dissection is a demanding operation and, in experienced centres, can be performed by a minimally invasive or robotic approach in selected cases, with less bleeding and a shorter recovery.
After treatment
Most of these patients have fifty years of life ahead of them, and that obliges us to think beyond cure:
- Follow-up with markers and imaging over several years, most intensive in the first two.
- Hormonal function. A proportion of patients develop low testosterone after orchidectomy or chemotherapy. It deserves measuring, not assuming.
- Late effects of chemotherapy: cardiovascular risk, neuropathy, hearing changes and a small increase in the risk of second tumours. They are another reason not to give chemotherapy to someone who does not need it.
- Self-examination of the remaining testicle, because the risk of a second tumour, though low, is real.
This is won or lost at the beginning
Why it matters who looks after you
This is a cancer that is almost always cured. For that very reason, what is at stake is not so much survival as how much treatment you will need to reach it, and with what lasting effects.
- Not violating the scrotumThe correct operation is through the groin, with control of the cord before the tumour is handled. A scrotal puncture or incision changes the lymphatic drainage and forces treatment to be added that would not otherwise have been needed.
- Offering sperm banking before, not afterIt is a window that closes. Raising it after chemotherapy is of no use, and it is among the omissions that weigh most ten years later.
- Sustaining surveillance in stage IIt is the preferred option and also the hardest to sustain: it demands explaining well why no treatment is given, and a schedule that is kept. Giving chemotherapy to everyone is easier; it is also worse.
- Knowing what to do with the residual massAfter chemotherapy, deciding whether to operate on the retroperitoneum and carrying out that dissection is one of the most demanding operations in urological oncology.
Put clearly: in this tumour almost nobody dies, but a great many people receive more treatment than they needed. Avoiding that is the job.
A urologic oncologist is a urologist who additionally completed a postgraduate fellowship devoted solely to urological cancer. Mine was at Centro Médico Nacional Siglo XXI, accredited by UNAM. It can be verified. What exactly changes →
Related guides
- Robotic surgery — including retroperitoneal lymph node dissection.
- Kidney cancer
- What is a urologic oncologist
- All patient guides
Excellent manner! A detailed explanation, and a favourable second opinion.
M. A. Verified appointment · Doctoralia · translated from Spanish
Dr. Eduardo Amaya Fragoso
Urologic Oncologist · Robotic Surgeon
Have you noticed a lump in your testicle?
Do not wait to see whether it goes away. An ultrasound and a blood marker panel settle the question in a day, and in this tumour weeks genuinely count. If you already have a diagnosis, bring your studies before anything is scheduled.
Available in person and by video consultation
Where I practise
Hospital San José, Hermosillo
Suite 301 · Module H · 3rd floor
Blvd. José María Morelos 340, Col. Bachoco, ZIP 83148
Hermosillo, Sonora
Appointments & info
662 111 0782
Hours
Monday to Friday · 8:00 AM – 8:00 PM
Saturday · 9:00 AM – 2:00 PM
Coming from another city? Travel times, length of stay and remote follow-up
Note
This information is for general guidance and does not replace a medical consultation: do not make decisions based on this text without discussing them with your urologist.